Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clobetasol Propionate for PIH Prevention After Laser Treatment of Facial Lentigines
NCT02492373Completed
- Sponsor
- Mahidol University
- Start
- Feb 2015
- Primary completion
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of clobetasol in Post-inflammatory hyperpigmentation (PIH), sponsored by Mahidol University. Primary endpoint: Incidence of post inflammatory hyperpigmentation at 2 weeks. Started Feb 2015; status: completed.
02
Drugs
clobetasol
03
Conditions
Post-inflammatory hyperpigmentation (PIH)
Beyond the preview
Go deeper on NCT02492373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02492373.